In light of these mechanisms, our study employs an intracerebral hemorrhage (ICH) murine model to investigate SPP1's therapeutic potential in ameliorating neurological deficits, cognitive dysfunction, and affective disorders including depression and anxiety‐like behaviors. This evidence concerns the gene SPP1 and depressive symptom measurement.